Outcomes of pleomorphic lobular carcinoma versus invasive lobular carcinoma

Waqar Haque, Ashley Arms, Vivek Verma, Sandra Hatch, E. Brian Butler, Bin S. Teh

Research output: Contribution to journalArticle

2 Citations (Scopus)

Abstract

Purpose: Pleomorphic lobular carcinoma (PLC) is a rare histologic variant of invasive lobular carcinoma (ILC) that has been associated with worse clinical outcomes than classic ILC. Owing to its rarity, high-volume studies of its clinical characteristics and prognosis are lacking. The purpose of this study was to use a large, contemporary cancer database to investigate the clinical characteristics and survival outcomes for patients with PLC. Methods: The National Cancer Database (NCDB) was queried for women with cT1-4N1-3M0 breast cancer with either ILC or PLC histology having received definitive surgical therapy. Chi-squared analysis was performed to determine differences between the cohorts. Kaplan-Meier analysis evaluated overall survival (OS) between all patients and between patients when stratifying by age and subtype. Cox proportional hazards modeling determined variables associated with OS. Results: A total of 115,260 patients met the study criteria; of these, 114,859 (99.6%) had ILC, while 401 (0.4%) had PLC. A greater proportion of patients with PLC had T3-4 and node-positive disease, and were more likely to have ER- and HER2+ disease. PLC histology was associated with worse OS on both univariate and multivariate analysis (p < 0.001). PLC was associated with poorer OS in subgroups that were T3-4/N+ (but not T1-2N0) disease and ER+ (but not ER-) cancers, but not by HER2 status. Conclusions: Patients with PLC, who were more likely to have ER- and HER2+ disease, experienced worse OS than patients with ILC, which may be limited to patients with more advanced clinical stage and ER + disease. Further work is needed to determine the optimal treatment for this more aggressive form of breast cancer.

Original languageEnglish (US)
Pages (from-to)67-73
Number of pages7
JournalBreast
Volume43
DOIs
StatePublished - Feb 1 2019

Fingerprint

Lobular Carcinoma
Survival
Histology
Databases
Breast Neoplasms
Neoplasms
Kaplan-Meier Estimate

Keywords

  • Breast cancer
  • Chemotherapy
  • Pleomorphic lobular breast cancer
  • Radiation therapy

ASJC Scopus subject areas

  • Surgery

Cite this

Outcomes of pleomorphic lobular carcinoma versus invasive lobular carcinoma. / Haque, Waqar; Arms, Ashley; Verma, Vivek; Hatch, Sandra; Brian Butler, E.; Teh, Bin S.

In: Breast, Vol. 43, 01.02.2019, p. 67-73.

Research output: Contribution to journalArticle

Haque, Waqar ; Arms, Ashley ; Verma, Vivek ; Hatch, Sandra ; Brian Butler, E. ; Teh, Bin S. / Outcomes of pleomorphic lobular carcinoma versus invasive lobular carcinoma. In: Breast. 2019 ; Vol. 43. pp. 67-73.
@article{1856c963854940cebf06f284b41ca4bd,
title = "Outcomes of pleomorphic lobular carcinoma versus invasive lobular carcinoma",
abstract = "Purpose: Pleomorphic lobular carcinoma (PLC) is a rare histologic variant of invasive lobular carcinoma (ILC) that has been associated with worse clinical outcomes than classic ILC. Owing to its rarity, high-volume studies of its clinical characteristics and prognosis are lacking. The purpose of this study was to use a large, contemporary cancer database to investigate the clinical characteristics and survival outcomes for patients with PLC. Methods: The National Cancer Database (NCDB) was queried for women with cT1-4N1-3M0 breast cancer with either ILC or PLC histology having received definitive surgical therapy. Chi-squared analysis was performed to determine differences between the cohorts. Kaplan-Meier analysis evaluated overall survival (OS) between all patients and between patients when stratifying by age and subtype. Cox proportional hazards modeling determined variables associated with OS. Results: A total of 115,260 patients met the study criteria; of these, 114,859 (99.6{\%}) had ILC, while 401 (0.4{\%}) had PLC. A greater proportion of patients with PLC had T3-4 and node-positive disease, and were more likely to have ER- and HER2+ disease. PLC histology was associated with worse OS on both univariate and multivariate analysis (p < 0.001). PLC was associated with poorer OS in subgroups that were T3-4/N+ (but not T1-2N0) disease and ER+ (but not ER-) cancers, but not by HER2 status. Conclusions: Patients with PLC, who were more likely to have ER- and HER2+ disease, experienced worse OS than patients with ILC, which may be limited to patients with more advanced clinical stage and ER + disease. Further work is needed to determine the optimal treatment for this more aggressive form of breast cancer.",
keywords = "Breast cancer, Chemotherapy, Pleomorphic lobular breast cancer, Radiation therapy",
author = "Waqar Haque and Ashley Arms and Vivek Verma and Sandra Hatch and {Brian Butler}, E. and Teh, {Bin S.}",
year = "2019",
month = "2",
day = "1",
doi = "10.1016/j.breast.2018.11.007",
language = "English (US)",
volume = "43",
pages = "67--73",
journal = "Breast",
issn = "0960-9776",
publisher = "Churchill Livingstone",

}

TY - JOUR

T1 - Outcomes of pleomorphic lobular carcinoma versus invasive lobular carcinoma

AU - Haque, Waqar

AU - Arms, Ashley

AU - Verma, Vivek

AU - Hatch, Sandra

AU - Brian Butler, E.

AU - Teh, Bin S.

PY - 2019/2/1

Y1 - 2019/2/1

N2 - Purpose: Pleomorphic lobular carcinoma (PLC) is a rare histologic variant of invasive lobular carcinoma (ILC) that has been associated with worse clinical outcomes than classic ILC. Owing to its rarity, high-volume studies of its clinical characteristics and prognosis are lacking. The purpose of this study was to use a large, contemporary cancer database to investigate the clinical characteristics and survival outcomes for patients with PLC. Methods: The National Cancer Database (NCDB) was queried for women with cT1-4N1-3M0 breast cancer with either ILC or PLC histology having received definitive surgical therapy. Chi-squared analysis was performed to determine differences between the cohorts. Kaplan-Meier analysis evaluated overall survival (OS) between all patients and between patients when stratifying by age and subtype. Cox proportional hazards modeling determined variables associated with OS. Results: A total of 115,260 patients met the study criteria; of these, 114,859 (99.6%) had ILC, while 401 (0.4%) had PLC. A greater proportion of patients with PLC had T3-4 and node-positive disease, and were more likely to have ER- and HER2+ disease. PLC histology was associated with worse OS on both univariate and multivariate analysis (p < 0.001). PLC was associated with poorer OS in subgroups that were T3-4/N+ (but not T1-2N0) disease and ER+ (but not ER-) cancers, but not by HER2 status. Conclusions: Patients with PLC, who were more likely to have ER- and HER2+ disease, experienced worse OS than patients with ILC, which may be limited to patients with more advanced clinical stage and ER + disease. Further work is needed to determine the optimal treatment for this more aggressive form of breast cancer.

AB - Purpose: Pleomorphic lobular carcinoma (PLC) is a rare histologic variant of invasive lobular carcinoma (ILC) that has been associated with worse clinical outcomes than classic ILC. Owing to its rarity, high-volume studies of its clinical characteristics and prognosis are lacking. The purpose of this study was to use a large, contemporary cancer database to investigate the clinical characteristics and survival outcomes for patients with PLC. Methods: The National Cancer Database (NCDB) was queried for women with cT1-4N1-3M0 breast cancer with either ILC or PLC histology having received definitive surgical therapy. Chi-squared analysis was performed to determine differences between the cohorts. Kaplan-Meier analysis evaluated overall survival (OS) between all patients and between patients when stratifying by age and subtype. Cox proportional hazards modeling determined variables associated with OS. Results: A total of 115,260 patients met the study criteria; of these, 114,859 (99.6%) had ILC, while 401 (0.4%) had PLC. A greater proportion of patients with PLC had T3-4 and node-positive disease, and were more likely to have ER- and HER2+ disease. PLC histology was associated with worse OS on both univariate and multivariate analysis (p < 0.001). PLC was associated with poorer OS in subgroups that were T3-4/N+ (but not T1-2N0) disease and ER+ (but not ER-) cancers, but not by HER2 status. Conclusions: Patients with PLC, who were more likely to have ER- and HER2+ disease, experienced worse OS than patients with ILC, which may be limited to patients with more advanced clinical stage and ER + disease. Further work is needed to determine the optimal treatment for this more aggressive form of breast cancer.

KW - Breast cancer

KW - Chemotherapy

KW - Pleomorphic lobular breast cancer

KW - Radiation therapy

UR - http://www.scopus.com/inward/record.url?scp=85059323986&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85059323986&partnerID=8YFLogxK

U2 - 10.1016/j.breast.2018.11.007

DO - 10.1016/j.breast.2018.11.007

M3 - Article

C2 - 30496936

AN - SCOPUS:85059323986

VL - 43

SP - 67

EP - 73

JO - Breast

JF - Breast

SN - 0960-9776

ER -